ADAG/ 12/16/2025 · 7:54 AM Adagene's Cancer Treatment Gets FDA Fast Track Status Adagene receives FDA Fast Track designation for muzastotug, a novel cancer therapy targeting hard-to-treat colorectal cancer patients.